Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Cellebrite DI Ltd.

MILWAUKEE, Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Cellebrite (NASDAQ: CLBT). The investigation results from inaccurate statements Cellebrite may have made regarding its financial statements, business operations and prospects.

The investigation focuses on recent disclosures regarding risks and Cellebrite's ability to execute with respect to U.S. federal and European government opportunities, which were encountering additional administrative and procurement requirements related to Cellebrite's foreign-entity status.

Click here to join our investigation or to obtain additional information, or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Ademi LLP

Guri Ademi

3620 East Layton Ave.

Cudahy, WI 53110

Toll Free: (866) 264-3995

Fax: (414) 482-8001

www.ademilaw.com

SOURCE Ademi LLP